BlossomHill Therapeutics, Inc.(BLSM)

Biotechnology · San Diego, CA

$19.94+0.25 (+1.27%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

BlossomHill Therapeutics (BLSM) EV/EBITDA: History & Chart | TGMCharts

EV/EBITDA Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T13:25:40.995Z.

Stored calculation inputs

Calculation as of: 2026-10-06T13:25:40.995Z.

Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 579,878,330
Total debt · period ending 2026-06-30: 23,371,000
Cash · period ending 2026-06-30: 95,376,000
TTM operating EBITDA · period ending 2026-06-30: N/A

FMP input reference: ade6551c806a0b8a23cc3b9f653dfce73cf5104c20f92b5c51aa4b81f5201f45

EV/Sales|P/E Ratio|EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

BLSM EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

BLSM Competitors' EV/EBITDA Ratio

BLSM

BlossomHill Therapeutics, Inc.

Current

Market Cap

$579.88M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AQST

Aquestive Therapeutics, Inc.

vs BLSM

Market Cap

$573.38M

EV/EBITDA Ratio

N/A

TTM Avg

42.12x

3Y Avg

42.12x

5Y Avg

42.12x

KIDS

OrthoPediatrics Corp.

vs BLSM

Market Cap

$587.93M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CRMD

CorMedix Inc.

vs BLSM

Market Cap

$569.56M

EV/EBITDA Ratio

1.82x

TTM Avg

5.90x

3Y Avg

15.41x

5Y Avg

15.41x

ACRS

Aclaris Therapeutics, Inc.

vs BLSM

Market Cap

$596.36M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CTMX

CytomX Therapeutics, Inc.

vs BLSM

Market Cap

$561.67M

EV/EBITDA Ratio

N/A

TTM Avg

13.55x

3Y Avg

10.69x

5Y Avg

10.69x

IRWD

Ironwood Pharmaceuticals, Inc.

vs BLSM

Market Cap

$600.84M

EV/EBITDA Ratio

3.86x

TTM Avg

7.68x

3Y Avg

8.80x

5Y Avg

8.39x

IMMX

Immix Biopharma, Inc.

vs BLSM

Market Cap

$551.09M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DCTH

Delcath Systems, Inc.

vs BLSM

Market Cap

$547.86M

EV/EBITDA Ratio

N/A

TTM Avg

144.36x

3Y Avg

144.36x

5Y Avg

144.36x

CLYM

Climb Bio, Inc.

vs BLSM

Market Cap

$632.76M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
BlossomHill Therapeutics, Inc. (BLSM)	$579.88M	N/A	N/A	N/A	N/A
Aquestive Therapeutics, Inc. (AQST)vs ›	$573.38M	N/A	42.12x	42.12x	42.12x
OrthoPediatrics Corp. (KIDS)vs ›	$587.93M	N/A	N/A	N/A	N/A
CorMedix Inc. (CRMD)vs ›	$569.56M	1.82x	5.90x	15.41x	15.41x
Aclaris Therapeutics, Inc. (ACRS)vs ›	$596.36M	N/A	N/A	N/A	N/A
CytomX Therapeutics, Inc. (CTMX)vs ›	$561.67M	N/A	13.55x	10.69x	10.69x
Ironwood Pharmaceuticals, Inc. (IRWD)vs ›	$600.84M	3.86x	7.68x	8.80x	8.39x
Immix Biopharma, Inc. (IMMX)vs ›	$551.09M	N/A	N/A	N/A	N/A
Delcath Systems, Inc. (DCTH)vs ›	$547.86M	N/A	144.36x	144.36x	144.36x
Climb Bio, Inc. (CLYM)vs ›	$632.76M	N/A	N/A	N/A	N/A

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics